Applications, hearings, determinations, etc.: High Standard Products Corp.,

[Federal Register: July 23, 2001 (Volume 66, Number 141)]

[Notices]

[Page 38321-38322]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr23jy01-109]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of title 21 of the Code of Federal Regulations

[[Page 38322]]

(CFR), this is notice that on January 4, 2001, High Standard Products Corp., 14441 Beach Boulevard, #225, Westminster, California 92683, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug

Schedule

Methaqualone (2565)........................ I Lysergic acid diethylamide (7315).......... I Tetrahydrocannabinols (7370)............... I 3,4-Methylenedioxyamphetamine (7400)....... I 3,4-Methylenedioxy-N-ethylamphetamine

I (7404). 3,4-Methylenedioxymethamphetamine (7405)... I 4-Methoxyamphetamine (7411)................ I Heroin (9200).............................. I 3-Methylfentanyl (9813).................... I Amphetamine (1100)......................... II Methamphetamine (1105)..................... II Secobarbital (2315)........................ II Phencyclidine (7471)....................... II Cocaine (9041)............................. II Codeine (9050)............................. II Hydromorphone (9150)....................... II Diphenoxylate (9170)....................... II Hydrocodone (9193)......................... II Methadone (9250)........................... II Morphine (9300)............................ II Fentanyl (9801)............................ II

The firm plans to manufacture analytical reference standards.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than September 21, 2001.

Dated: July 13, 2001. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 01-18216Filed7-20-01; 8:45 am]

BILLING CODE 4410-09-M